Osseointegration of dental implants can be promoted by implant-surface modifications using bisphosphonate coatings. In addition, it is of clinical interest to promote peri-implant bone formation and to restore bony structure in low bone-mass patients. The present study evaluated a combination of an anti-resorptive zoledronic acid (ZOL) implant-coating and a systemically applied sclerostin antibody, a known bone anabolic treatment principle, versus sole sclerostin antibody treatment or ZOL implant-coating in a rat osteoporosis model.
Find out more
Join our next Thommen Talk Series Webinar on June 15th!
Mon, June 15th, 2020 6:00 - 7:00 PM CEST (Zürich) / 12:00 - 01:00 PM EST (New York) - Aestetics in Implant Dentistry: A biological Perspective.…